Autoimmunity may play a role in myelodysplasia for some patients, and immunosuppression in these patients may be beneficial. Saunthararajah et al developed a model for identifying patients with MDS likely to respond to immunosuppression. The authors are from the University of Illinois at Chicago and the National Heart, Lung, and Blood Institute at NIH.

To read more or access our algorithms and calculators, please log in or register.